The company manufactures and exports eco-friendly bags made from cotton and jute, primarily serving international retail and promotional markets while recently diversifying into polyester backpacks.
The company lacks a durable moat as evidenced by low net margins and a business model heavily dependent on low-cost labor and commodity raw materials. While certifications provide a baseline for export entry, they do not prevent intense competition from other low-cost manufacturing hubs like Bangladesh and Vietnam.
Capital has been primarily directed toward expanding manufacturing capacity in West Bengal and Gujarat, funded by IPO proceeds and internal accruals. While revenue is growing, the massive equity dilution from the IPO has significantly lowered the return on net worth in the short term.
Five years out, the investment collapsed because the company failed to translate revenue growth into shareholder value. The massive equity dilution from the IPO permanently suppressed per-share earnings, while the negative cash conversion cycle forced the business into a liquidity trap. As competition from lower-cost manufacturing hubs intensified, the already thin net margins evaporated. The departure of the CFO was a harbinger of the internal control lapses that eventually led to a total breakdown in financial reporting, leaving investors with a business that grew its top line while incinerating its capital base.
RichFakir rates Ecoline Exim Ltd's business quality as poor — 39/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Ecoline Exim Ltd is trading about 25% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Ecoline Exim Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Ecoline Exim Ltd's fair value is about ₹146 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →